Dasatinib for HIV-1 Reservoir Reduction
Dasatinib for HIV-1 Reservoir Reduction
Recruiting · NCT07342491 · Registry updated 2026-08-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dasatinib for HIV-1 Reservoir Reduction | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 1 | 2026-08-04 | NCT07342491 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| 1401, University of Washington Positive Research CRS | Seattle | United States | 2 |
| 2501, Case CRS | Cleveland | United States | 2 |
| Northwestern University CRS (Site # 2701) | Chicago | United States | 1 |